New Market Report: Sri Lanka Pharmaceuticals & Healthcare Report Q3 2016

Despite Sri Lanka's short-term fiscal challenges, the country's pharmaceutical and healthcare markets will continue to expand over the forecast period. In fact, under the FY2016 budget, the government outlined the construction and upgrade of several healthcare facilities, which will broaden access to health services in the country while strengthening the health system ability to cope with latent and growing demand for treatment of chronic diseases. However, public spending figures will observe partial cuts or adjustments as part of the country's recent agreement to secure an international bail out loan, while we expect pro-generic medicines policies and low per-capita drug spending to limit Sri Lanka's appeal to innovative pharmaceutical investors.

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

Full Report Details at
- http://www.fastmr.com/prod/1182827_sri_lanka_pharmaceuticals.aspx?afid=301

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- Brazil Pharmaceuticals & Healthcare Report Q3 2016
- Czech Republic Pharmaceuticals & Healthcare Report Q3 2016
- Bahrain Pharmaceuticals & Healthcare Report Q3 2016
- China Pharmaceuticals & Healthcare Report Q3 2016
- Egypt Pharmaceuticals & Healthcare Report Q3 2016